All Stories

  1. Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study
  2. Riedel’s thyroiditis: clinical presentation, treatment and outcomes
  3. Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia
  4. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center
  5. Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease
  6. Rescue pre-operative treatment with Lugol’s solution in uncontrolled Graves’ disease
  7. The relationship between thyroid hormone levels and cognitive functions in Graves’ disease might be influenced by a history of mild traumatic brain injury
  8. Frequency of Cushing’s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center
  9. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids – experience from a single centre spanning three decades
  10. Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations
  11. A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms
  12. Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study
  13. Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy
  14. Ileal neuroendocrine tumors and heart: not only valvular consequences
  15. High rates of fatigue in newly diagnosed Graves' disease
  16. 68Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors
  17. Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel® given by either self/partner or a health care professional
  18. Thyrotoxic periodic paralysis: clinical and molecular aspects
  19. Antibodies to citrullinated protein antigen are not biomarkers for Grave's ophalmopathy
  20. Alcohol Intake and Its Effect on Some Appetite-Regulating Hormones in Man: Influence of Gastroprotection with Sucralfate
  21. Incidence of hyperthyroidism in Sweden
  22. Thyroxin substitution and open-angle glaucoma: a nationwide register-based study on filled prescriptions
  23. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine
  24. Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131
  25. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005.
  26. Alcohol-Induced Disruption of Endocrine Signaling
  27. Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects
  28. Graves' Disease: A Long-Term Quality-of-Life Follow Up of Patients Randomized to Treatment with Antithyroid Drugs, Radioiodine, or Surgery
  29. Inhibitory effect of alcohol on ghrelin secretion in normal man
  30. Hunger–Satiety Signals in Patients with Graves' Thyrotoxicosis Before, During, and After Long-Term Pharmacological Treatment
  31. IS DECREASED LEPTIN SECRETION AFTER ALCOHOL INGESTION CATECHOLAMINE-MEDIATED?
  32. Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals